Male
Multidisciplinary Team(s)
Head Neck Oncology
Melanoma/Skin
Department/Research Program(s)
Department of Oncology
Developmental Therapeutics
Molecular Biology and Genetics
Cancer Type(s)
Esophageal Cancer
Laryngeal Cancer
Salivary Gland Cancer
Nasopharyngeal Cancer
Nose Cancer
Oropharynx (soft palate
Thyroid Cancer
Lip/Oral Cavity (hard palate
Sinus Cancer
Throat Cancer
Melanoma
Skin Cancer (Basal Squamous Cell)
Neck Cancer
Contact Info
Email:
yoog@karmanos.org
来自 http://www.karmanos.org/physicians/George-Yoo?Disease=215PageIndex=1SortDirection=1
Education
Fellowship
Academic Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland
Medical School
University of Kansas Medical Center
Residency
Otolaryngology, Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, MD
Professional Memberships/Associations
American Academy of Otolaryngology-Head and Neck Surgery
Radiation Therapy oncology Group (Head and Neck Committee)
American Society of Clinical Oncology
Southwest oncology Group (Board of Governors, Melanoma Committee, Chair, Surgical Committee and Gene Therapy Sub-committee)
American College of Surgeons
Michigan Otolaryngological Society
Board Certifications
American Board of Otolaryngology
Clinical Interests
Head and Neck - Surgeon
Research Interests
Gene therapy for head and neck cancer, and clinical trials in head and neck cancer.
Awards
Voted one of Best Doctors Inc. 2011-2014 Best Doctors of the Year
Publications
Fine Needle Aspiration of Head and Neck Masses in the Operating Room: Accuracy and Potential Benefits. Diag. Cytopath 36(6):369-374, 2008. Authors: Yousef N; Arabi MH; Feng J; Yoo GH; Al-Abbadi MA.
Docetaxel Effects on the Surgical Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg, 134(7):735-742, 2008. Authors: Yoo GH; Subramanian G; Piechocki MP; Ensley JF; Tulunay OE; Lonardo F; Kim H; Won J; Stevens T; Lin HS.
Craniocervical Necrotizing Fasciitis with and without Thoracic Extension-Management Strategies and Outcome. Am J Oto, 30(1):17-23, 2009. Authors: Mao JC; Carron MA; Fountain K; Stachler RJ; Yoo GH; Mathog RH; Coticchia JM;.
A Phase II Trial of Surgery with Perioperative INGN 201 (Ad5CMV-p53) Gene Therapy Followed by Chemoradiotherapy for Advanced, Resectable Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx and Larynx: REPORT OF THE SOUTHWEST onCOLOGY GROUP. Arch Otolaryngol Head Neck Surg, 135(9):869-874, 2009. Authors: Yoo GH; Moon J; Tsue T; Girod D; Kim H; Lonardo F; Wolf G; Valentino J; Hanna E; LeBlanc M; Ensley JF; Urba S.
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck. Clin Can Res 15(24):7719-7725, 2009. Authors: Nemunaitis J, Clayman G, Agarwala SS, Hrushesky W, Wells JR, Moore C, Hamm J, Yoo GH, baselga J, Murphy BA, Menander KA, Licato LL, Chada S, Gibbons RD, Olivier M, Hainaut P, Roth JA, Sobol RE, Goodwin WJ.
